Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Nu Skin
NUS
Market cap
$388M
Overview
Fund Trends
Analyst Outlook
Journalist POV
7.90
USD
+0.25
3.27%
At close
Updated
Apr 17, 4:00 PM EDT
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
3.27%
5 days
5.76%
1 month
8.67%
3 months
-28.57%
6 months
-26.1%
Year to date
-18.47%
1 year
44.16%
5 years
-85.25%
10 years
-80.34%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
47.4%
Negative
Positive
Neutral
Negative
Neutral
Business Wire
5 days ago
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2026 results after the market closes on Thursday, May 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.
Neutral
Business Wire
16 days ago
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for beauty and wellness device systems,* today announced the general consumer availability in the U.S. of Prysm iO™, a breakthrough intelligent nutritional wellness platform designed to deliver a better understanding of how daily nutrition and supplement routines support overall wellness. Prysm iO will launch for consumers in other Nu Skin markets in the coming months. Compact, portable and powered by adv.
Positive
Seeking Alpha
16 days ago
71 April Graham Value All-Stars (GVAS): 14 To Buy
The April 2026 GASV list highlights 14 fair-priced, 'safer' mid-to-large-cap value stocks with strong dividend profiles and positive free-cash-flow-yields. Top ten GASV stocks are projected to deliver average net gains of 43.98% by April 2027, with yields ranging from 7.47% to 13.59%. All top-ten GASV stocks are ideally priced, with dividends from $1K invested exceeding their share prices, though some financials fund dividends with borrowed money.
Neutral
Business Wire
29 days ago
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas stepped down as CFO to pursue an outside opportunity. “On behalf of our board, management and the entire Nu Skin team, we thank James for his leadership and significant contributions over 16 years at Nu Skin and wish him and his family well in their future pursuits,” said.
Positive
Seeking Alpha
1 month ago
14 Ideal 'Safer' Dividend Buys From 70 Mid-March Graham Value All-Stars (GVAS)
Top ten large cap value (GASV) stocks are forecasted to deliver an average 38.12% net gain by mid-March 2027, with yields up to 13.03%. Analyst targets suggest the five lowest-priced, highest-yield GASV stocks could outperform, offering an 18.5% higher gain than the top ten as a group. Fourteen of twenty-nine 'safer' lowest-priced GASV stocks are currently buyable, with seven meeting the ideal dividend-to-price criteria for fair value.
Neutral
Business Wire
1 month ago
Nu Skin Appoints Chayce Clark as COO
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leading the company's revenue performance and end-to-end operational execution across the business in addition to maintaining his role as the company's chief legal officer. “Chayce has been a valuable part of our executive team and an important voice in our efforts to become the world's leading intellige.
Positive
Seeking Alpha
1 month ago
14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)
March's Large Cap Value (GASV) screen highlights 14 fair-priced, 'safer' dividend stocks, including Hafnia Ltd, IRSA Inversiones, and Weibo Corp, as actionable buys. Top ten GASV stocks are projected to deliver an average 33.21% net gain by March 2027, with risk/volatility slightly below the market average. Analyst targets indicate the five lowest-priced, highest-yield GASV stocks could outperform, with Hafnia Ltd showing a potential 42.88% gain.
Positive
Seeking Alpha
1 month ago
Nu Skin: Patience Is Still Advised
Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin expansion and a return to revenue growth by late 2026, with India and Prysm iO launches as key potential drivers. Non-core assets and a net cash-positive balance sheet provide some downside protection, but secular decline in legacy markets remains a major overhang.
Positive
Seeking Alpha
1 month ago
Nu Skin Still Has Long-Term Turnaround Potential
Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS's core MLM business faces structural decline, but new product and market initiatives could stabilize or grow revenue beyond 2026. Prysm iO potential subscription fees may provide incremental revenue not fully reflected in current guidance.
Negative
Zacks Investment Research
2 months ago
Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y
NUS' fourth-quarter earnings and sales miss estimates, with revenues down 16.9% Y/Y and broad declines across key global regions.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close